To know the efficacy of two unani formulations in deranged lipid levels

Not yet recruiting

• Conditions: Hyperlipidemia, unspecified,

• Registration Number: CTRI/2022/09/045383
• Lead Sponsor: Department of moalajat Ajmal khan Tibbiya college Aligarh Muslim university Aligarh

Brief Summary

Dyslipidemia is the  disease in which there is derrangement of lipid metabolism.. There are various drugs used to treat this condition. But i am want try to find out a holistic medicine for this condition.. Due to above reason I selected this topicvfor my research work

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-09-09
• Study Start: 2022-09-26

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

A) Patients between 30-60 years of age, both male and female B) Patient ready to participate in the study and ready to follow the instructions Subjective criteria: a) Increased body weight b) Dyspnea on exertion c) Fatigue d) Xanthelasma e) Xanthoma f) Corneal arcus Objective criteria Lipid profile: Serum cholesterol: 200-300mg/dl Serum triglycerides: 200-300mg/dl Serum HDL: 30-50 mg/dl Serum LDL: 100-150 mg/dl Serum VLDL: 30-50 mg/dl BMI: 25-30kg/m2.

Exclusion Criteria

Exclusion criteria: A) Pregnacy and lactation B) Diabetic patient having HBAlc>8 % and FBS >250 mg /dl C) Diabetes mellitus with complications like Diabetic ketoacidosis, retinopathy, Nephropathy, CHD, CVD etc D) Several liver and renal diseases E) Severe systemic illnesses F) Patient who failed to follow up.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in following objective criteria	Three months with fortnightly follow-up
Serum HDL: 30-50 mg/dl Serum LDL: 100-150 mg/dl Serum VLDL: 30-50 mg/dl	Three months with fortnightly follow-up
BMI:	Three months with fortnightly follow-up
25-30kg/m2	Three months with fortnightly follow-up
Lipid profile:	Three months with fortnightly follow-up
Serum cholesterol:200-300mg/dl Serum triglycerides:200-300mg/dl	Three months with fortnightly follow-up

Secondary Outcome Measures

Name	Time	Method
Improvement in subjective criteria such as	Dyspea

Trial Locations

Locations (1)

Ajmal khan tibbiya college hospital; 🇮🇳 Aligarh, UTTAR PRADESH, India

Ajmal khan tibbiya college hospital

🇮🇳Aligarh, UTTAR PRADESH, India

Sayeedur Rahman

Principal investigator

09870906771

sayeedkhanalig@gmail.com